항생제
Dapsone

Dapsone

Spectrum Of Activity

General Information

  • Dermatitis herpetiformis
  • Leprosy in combination with other anti-leprosy medications
  • Acne

Monitor CBC weekly for first month then monthly for 6 months.

Monitor liver function at baseline, then periodically throughout therapy.

In HIV patients, monitor CBC platelets and reticulocyte counts, every 2-3 days during first 2-3 weeks, then monthly for the first 3 months, and then every 6 months.

Common

  • Dry skin
  • Peeling of skin
  • Erythema

Serious

  • Bullous dermatosis
  • Erythema multiforme
  • Erythema nodosum
  • Erythema scarlatiniforme
  • Erythroderma
  • Toxic epidermal necrolysis
  • Toxic erythema
  • Acquired Heinz body anemia
  • Agranulocytosis
  • Aplastic anemia
  • Hemolysis
  • Hemolytic anemia
  • Methemoglobinemia
  • Cholestatic jaundice syndrome
  • Toxic hepatitis
  • Peripheral motor neuropathy
  • Infectious mononucleosis
  • Warfarin- may result in increased INR
  • Zidovudine- may result in hematologic toxicity

Antimicrobial class: Sulfone

Pregnancy category: C

Average serum half life: 10-50 hours (average 28 hours)

Precautions: Dose-related hemolytic anemia, hemolysis and hepatotoxic reactions have been reported with oral treatment, especially in individuals with G6PD deficiency; discontinue if signs and symptoms occur.

Discontinue if new or toxic skin reactions occur.

Monitoring recommended and discontinue if significant reduction in leukocytes, platelets, or hemopoiesis occurs.

Treat severe anemia prior to oral dapsone initiation; monitoring recommended.